Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 11233895 | HLA-DR (HLA-DR) | lung transplantation | NA | NA | NA | unclassified | |
| long-term outcome of lung transplantation is predicted by the number of hla-dr mismatches. | |||||||
| 11233895 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| the importance of hla mismatch in determining long-term outcome in lung transplantation remains largely uncertain. | |||||||
| 11233895 | HLA-DR (HLA-DR) | lung transplantation | NA | NA | NA | unclassified | |
| improved outcome after lung transplantation might be achieved with prospective matching for hla-dr. alternatively, the amount and type of immunosuppressive drugs may be guided by the degree of hla-dr (mis)matching. | |||||||
| 15387100 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| long-term survival after lung transplantation was influenced by hla matching. | |||||||
| 17178336 | NA (NA) | lung transplantation | NA | NA | NA | only_studied | |
| identification of non-hla target antigens recognized after lung transplantation. | |||||||
| 17543791 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| hyperacute rejection after lung transplantation caused by undetected low-titer anti-hla antibodies. | |||||||
| 17543791 | HLA (HLA) | lung transplantation | NA | NA | NA | negation | |
| we report a case of fatal early graft dysfunction after lung transplantation in a female recipient with no anti-hla ab detected before transplantation. | |||||||
| 18645500 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lung transplantation | NA | NA | NA | negation | |
| a simultaneous determination of vascular c4d with soluble c4d in broncho-alveolar lavage fluid (bal) and circulating anti-human leukocyte antigen (hla) antibodies (hla-ab) has not been reported in lung transplantation. | |||||||
| 20558084 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lung transplantation | NA | NA | NA | unclassified | |
| anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. | |||||||
| 20558084 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lung transplantation | NA | NA | NA | unclassified | |
| because the development of donor-specific anti-human leukocyte antigen (hla) antibodies (dsa) after lung transplantation has been associated with acute and chronic rejection, we implemented a clinical protocol to screen all transplant recipients for dsa and preemptively treat those who developed dsa with rituximab and intravenous immune globulin (ivig), or ivig alone. | |||||||
Copyright 2024